Loading people...
Loading people...
Co-Founder at Australian Medical Angels
Amandeep Hansra is a Principal at Main Sequence Ventures, a leading deep tech venture capital firm. He plays a key role in identifying and investing in science-backed startups with the potential for global impact.
Amandeep Hansra invests in deep technology companies across various sectors. His focus includes areas like artificial intelligence, quantum computing, advanced materials, biotechnology, sustainable energy, and space technology, all stemming from scientific breakthroughs.
Amandeep Hansra works as a Principal at Main Sequence Ventures. This firm is dedicated to commercializing Australian scientific research and building global deep tech companies.
Dr. Amandeep Hansra is a Principal at venture syndicate TEN13, the Co-founder of Australian Medical Angels, and a practicing physician based in Sydney, Australia. She previously served as the Chief Executive Officer and Co-founder of Telstra ReadyCare, a telemedicine joint venture, and worked as the Chief Medical Officer for Medgate Australia. Hansra holds a Global Executive MBA and a Master of Public Health from the University of Sydney, and she was appointed to the board of the Australian Digital Health Agency in 2021. Additionally, she founded Creative Careers in Medicine, a professional organization that has grown to support a community of over 20,000 medical professionals exploring non-clinical career paths. Her current focus centers on leveraging her clinical expertise to lead early-stage healthtech, medtech, and digital health investments across the broader Australian venture capital ecosystem.
Amandeep Hansra is a distinguished Principal at Main Sequence Ventures, a pioneering deep tech venture capital firm dedicated to building the next generation of global companies from Australia's scientific breakthroughs. In his pivotal role, Amandeep is instrumental in identifying, evaluating, and nurturing early-stage and growth-stage companies that are leveraging cutting-edge science and engineering to solve some of the world's most pressing challenges.
Main Sequence Ventures, founded by CSIRO, has a unique mandate to commercialize Australia's world-class research. Amandeep's work directly contributes to this mission by sourcing promising ventures, conducting rigorous due diligence, and providing strategic support to portfolio companies. His investment focus areas typically span the broad spectrum of deep technology, including but not limited to artificial intelligence, quantum computing, advanced materials, biotechnology, sustainable energy solutions, and space technology. He is passionate about ventures that possess significant intellectual property, defensible technology, and the potential for massive global impact.
While specific details of Amandeep Hansra's career background and individual notable investments are not always publicly detailed, his position as a Principal at Main Sequence Ventures suggests a strong foundation in technology, venture capital, or a related field that equips him with the expertise to assess complex scientific innovations and market opportunities. Professionals in such roles often bring a blend of scientific acumen, entrepreneurial experience, and financial insight, enabling them to guide founders through the challenging journey from lab to market. His involvement underscores Main Sequence Ventures' commitment to partnering with visionary founders who are transforming industries and creating new ones.
Amandeep's contributions are vital to Main Sequence Ventures' strategy of investing in companies that are not just incrementally better, but fundamentally new. He works closely with founders, offering mentorship, connecting them with critical resources, and helping them scale their operations to achieve global reach. His dedication helps ensure that Australia's scientific prowess translates into tangible economic growth and societal benefit, fostering a vibrant ecosystem for deep tech innovation.
